Related Experiment Videos
Multiple drug resistance in the pathogenic protozoa
1Queensland Institute of Medical Research, Bancroft Centre, Brisbane, Australia.
Acta Tropica
|March 1, 1994
Summary
Multiple drug resistance (MDR) in pathogenic protozoa is examined, comparing their mdr genes and efflux transporters to mammalian counterparts. Understanding MDR in protozoa requires a broader context of ATP-binding cassette (ABC) transporters.
Area of Science:
- Molecular Biology
- Parasitology
- Biochemistry
Background:
- Multiple drug resistance (MDR) is a significant challenge in treating pathogenic protozoa.
- MDR efflux transporters and their associated mdr genes are well-characterized in mammalian cells.
- Protozoan MDR mechanisms share similarities with, yet possess unique characteristics compared to, mammalian systems.
Purpose of the Study:
- To examine evidence for MDR in pathogenic protozoa.
- To compare protozoan mdr gene homologues and their roles in drug efflux with mammalian MDR systems.
- To explore the broader context of ATP-binding cassette (ABC) transporters in understanding MDR.
Main Methods:
- Comparative analysis of mdr gene families in protozoa and mammals.
- Review of existing evidence on drug efflux mechanisms in pathogenic protozoa.
- Examination of the substrate range, kinetics, structure, and bioenergetics of MDR transporters.
Main Results:
- Evidence for MDR phenomena in pathogenic protozoa is presented.
- Homologues of the mdr gene family in protozoa are identified and compared to mammalian MDR.
- The broad substrate specificity of ATP-binding cassette (ABC) transporters, including MDRs, is highlighted.
Conclusions:
- MDR in protozoa shares characteristics with mammalian MDR, involving efflux transporters and mdr genes.
- A comprehensive understanding of protozoan MDR necessitates considering the broader family of ABC transporters.
- The complex transport mechanisms of MDR efflux transporters are better understood within a wider biological context.